Safety and Performance of PEEK Anchors (Dynomite, Spyromite, Raptomite) in Extremities

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Bunionectomy Clinical Trial

Official title:
Safety and Performance of PEEK Anchors (Dynomite, Spyromite, Raptormite, Footprint Ultra PK SL) in Extremities

Status Completed

Clinical Trial Summary

Safety and performance of the study devices in extremities over a time period of 6 months after intervention.

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT00609466` - A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy	Phase 3
Terminated	`NCT00209560` - A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures	Phase 3
Completed	`NCT00293631` - Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy	Phase 2
Withdrawn	`NCT05087914` - Novel Non-opioid Post-surgical Pain Treatment in Females	Phase 2
Completed	`NCT04855240` - Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy	Phase 2
Completed	`NCT05157841` - Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy	Phase 3